Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Amortization of Deferred Charges (2020 - 2025)

Xeris Biopharma Holdings' Amortization of Deferred Charges history spans 6 years, with the latest figure at $866000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Amortization of Deferred Charges rose 7.31% year-over-year to $866000.0, compared with a TTM value of $3.3 million through Dec 2025, up 9.6%, and an annual FY2025 reading of $3.4 million, up 12.17% over the prior year.
  • Amortization of Deferred Charges for Q4 2025 was $866000.0 at Xeris Biopharma Holdings, up from $800000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $866000.0 in Q4 2025, with the low at $200000.0 in Q2 2021.
  • Average Amortization of Deferred Charges over 5 years is $547400.0, with a median of $536500.0 recorded in 2022.
  • Year-over-year, Amortization of Deferred Charges crashed 33.33% in 2021 and then surged 150.0% in 2022.
  • Tracing XERS's Amortization of Deferred Charges over 5 years: stood at $273000.0 in 2021, then soared by 68.13% to $459000.0 in 2022, then rose by 8.93% to $500000.0 in 2023, then surged by 61.4% to $807000.0 in 2024, then grew by 7.31% to $866000.0 in 2025.
  • Per Business Quant, the three most recent readings for XERS's Amortization of Deferred Charges are $866000.0 (Q4 2025), $800000.0 (Q3 2025), and $800000.0 (Q2 2025).